- 全部删除
- 您的购物车当前为空
Ticagrelor-d7 是 Ticagrelor 的氘代化合物。Ticagrelor 的 CAS 号为 274693-27-5。Ticagrelor (AZD6140) 是可逆的,可口服的P2Y12受体拮抗剂,可抑制血小板聚集。
Ticagrelor-d7 是 Ticagrelor 的氘代化合物。Ticagrelor 的 CAS 号为 274693-27-5。Ticagrelor (AZD6140) 是可逆的,可口服的P2Y12受体拮抗剂,可抑制血小板聚集。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | 待询 | 20日内发货 | |
5 mg | 待询 | 20日内发货 |
Ticagrelor-d7 相关产品
产品描述 | Ticagrelor-d7 is a deuterated compound of Ticagrelor. Ticagrelor has a CAS number of 274693-27-5. Ticagrelor, produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique(EU) and Possia(EU). |
别名 | 替卡格雷-d7 |
分子量 | 529.61 |
分子式 | C23H21D7F2N6O4S |
CAS No. | 1265911-55-4 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容